These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2197559)

  • 1. First UK trial of AIDS vaccine approved.
    Concar D
    Nature; 1990 Jul; 346(6282):303. PubMed ID: 2197559
    [No Abstract]   [Full Text] [Related]  

  • 2. U.K. vaccine trial: stalking horse for the future.
    Cherfas J
    Science; 1990 Aug; 249(4969):626. PubMed ID: 2166340
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive immunization in ARC and AIDS.
    Karpas A; Gray J; Byron N; Gilgen D; Bally V; Oates JK; Gazzard B
    Biotherapy; 1990; 2(2):159-72. PubMed ID: 2144762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for an AIDS vaccine.
    Girard M
    Cancer Detect Prev; 1990; 14(3):411-3. PubMed ID: 2117487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the progression to AIDS.
    Polis MA; Masur H
    Am J Med; 1990 Dec; 89(6):701-5. PubMed ID: 1979204
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
    N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate markers for AIDS treatment.
    Jacobson M
    Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
    [No Abstract]   [Full Text] [Related]  

  • 10. Discriminating between protective and enhancing HIV antibodies.
    Bernard J; Reveil B; Najman I; Liautaud-Roger F; Fouchard M; Picard O; Cattan A; Mabondzo A; Laverne S; Gallo RC
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):243-9. PubMed ID: 2109624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS vaccine predictions.
    Barin F
    Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526
    [No Abstract]   [Full Text] [Related]  

  • 12. [ Biological criteria for prediction of the clinical course leading to AIDS].
    Salmon D; Couroucé AM; Doinel C; Fine JM; Kaplan C; Lambin P; Lefrère JJ; Rouger P; Salmon C
    Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):407-14. PubMed ID: 1981002
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone reduces levels of AIDS virus in blood.
    Oncology (Williston Park); 1989 Oct; 3(10):19. PubMed ID: 2518005
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
    Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
    J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma viremia in human immunodeficiency virus infection.
    Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
    N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Promising results with the anti-HIV vaccine].
    Katlama C
    Presse Med; 2003 Jun; 32(21):964. PubMed ID: 12876523
    [No Abstract]   [Full Text] [Related]  

  • 18. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
    Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM
    N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS vaccines inch closer to useful existence.
    Goldsmith MF
    JAMA; 1991 Mar; 265(11):1356-7. PubMed ID: 1999873
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-1 isolation and p24-antigen detection in cerebrospinal fluid of subjects with neurological abnormalities related to AIDS.
    D'Agaro P; Andrian P; Roscioli B; Mascioli M; Dal Molin G; Comar M; Faruzzo A; Majori L
    Acta Neurol (Napoli); 1990 Feb; 12(1):49-52. PubMed ID: 2110717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.